Multimodal deep learning radiomics model for predicting esophageal fistula after chemotherapy and/or radiotherapy in esophageal squamous cell carcinoma: a multicenter study
Frontiers in Oncology · 16.11.2026 · 16
DOI: 10.3389/fonc.2026.1910607 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 16.11.2026. Verfasst von Xuezhi Li und 9 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objectives
This study aims to develop a multimodal model that integrates deep learning radiomics and clinical characteristics to predict the risk of esophageal fistula (EF) after chemotherapy and/or radiotherapy in patients.
Methods
In this multicentre retrospective study, 186 patients with esophageal squamous cell carcinoma (ESCC) from three institutions were allocated into training (n = 80), internal validation (n = 35), and external validation (n = 71) cohorts. Clinical data were extracted from electronic medical records, and radiomic features were extracted from pretreatment contrast-enhanced CT images. Deep transfer learning features were extracted using residual network-50 (ResNet-50) and combined with radiomic features to construct deep transfer learning radiomics (DTLR) features. Single-modality models based on clinical characteristics, radiomic features, and DTLR features were developed, respectively. A multimodal fusion model was then constructed using decision-level fusion. Model performance was evaluated in terms of discrimination, calibration, and clinical utility, using metrics including the area under the receiver operating characteristic curve (AUC), accuracy (ACC), and sensitivity.
Results
The multimodal combined model achieved AUCs of 0.957 (95% confidence interval [CI]: 0.917–0.996), 0.922 (95% CI: 0.837–1.000), and 0.865 (95% CI: 0.783–0.948) in the training, internal validation and external validation cohorts, respectively. The combined model achieved higher AUC values than the clinical, radiomics, and DTLR models across all cohorts, although the incremental benefit over the DTLR model was not statistically significant in any cohort. Decision curve analysis demonstrated that the multimodal model provided greater clinical net benefit than each single-modality model.
Conclusion
The multimodal model integrating clinical, radiomics and DTLR features showed favorable performance for predicting EF after chemotherapy and/or radiotherapy in patients with ESCC. This model may facilitate the identification of high-risk patients and provide guidance for optimizing individualized treatment strategies.
Zitieren
APA
Li, X., Zhang, H., Li, P., Wang, C., Guan, C., Chen, Y., Li, C., Li, Y., Li, W., & Yue, J. (2026). Multimodal deep learning radiomics model for predicting esophageal fistula after chemotherapy and/or radiotherapy in esophageal squamous cell carcinoma: a multicenter study. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1910607
Vancouver
Li X, Zhang H, Li P, Wang C, Guan C, Chen Y, et al. Multimodal deep learning radiomics model for predicting esophageal fistula after chemotherapy and/or radiotherapy in esophageal squamous cell carcinoma: a multicenter study. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1910607
BibTeX
@article{Li2026,
author = {Li, Xuezhi and Zhang, Haohan and Li, Pei and Wang, Chenyu and Guan, Cancan and Chen, Yuqin and Li, Chenyu and Li, Yichen and Li, Weixing and Yue, Junyan},
title = {Multimodal deep learning radiomics model for predicting esophageal fistula after chemotherapy and/or radiotherapy in esophageal squamous cell carcinoma: a multicenter study},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1910607}
}
EUVIMED